CME
Latest Episodes
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Host: Nilika Singhal, MD Guest: M. Scott Perry, MD Guest: Elizabeth Anne Thiele, MD, PhD Lennox-Gastaut syndrome and Dravet syndrome are 2 rare epileptic disorders with a pediatric onset. Theyre often refractory to therapy and have sign
Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
Host: Mark Socinski, MD Guest: Patrick Forde, M.B.B.Ch. The optimal management of non-small cell lung cancer (NSCLC) has fundamentally changed. Targeted agents, mono and combination immunotherapy, and immunochemotherapy options continue to e
Keeping Pace in Lung Cancer Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
Host: Mark Socinski, MD Guest: Kristin Higgins, MD The clinical value of adding immunotherapy together with chemoradiation in locally advanced non-small cell lung cancer (NSCLC) has been evident since 2017. This concept has been extended thr
How, When, and Why to Conduct Brief AUD Interventions
Guest: Edwin A. Salsitz, MD, DFASAM The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders worldwide. Our multidisci
Strategies for Referral to AUD Treatment
Host: Annie Levesque, MD, MSc Guest: Ethan A. Cowan, MD The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disorders w
Selecting an AUD Treatment: Naltrexone
Guest: Ethan A. Cowan, MD Guest: Edwin A. Salsitz, MD, DFASAM The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disor
Selecting an AUD Treatment: Acamprosate
Host: Edwin A. Salsitz, MD, DFASAM Guest: Ethan A. Cowan, MD The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disord
Selecting an AUD Treatment: Disulfiram
Host: Edwin A. Salsitz, MD, DFASAM Guest: Ethan A. Cowan, MD The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disord
Selecting an AUD Treatment: Off-Label Agents
Guest: Ethan A. Cowan, MD Guest: Edwin A. Salsitz, MD, DFASAM The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse disor
Case-Based AUD Challenge
Host: Annie Levesque, MD, MSc Guest: Edwin A. Salsitz, MD, DFASAM The burden of Alcohol Use Disorder (AUD) is often overshadowed by the widespread opioid epidemic; however, AUD is one of the most prevalent and life-altering substance abuse d